Streetbeat News

Partnerships

KA

MRK

Kineta has reopened enrollment for its VISTA-101 clinical trial, which evaluates KVA12123 in patients with advanced solid tumor cancer. The trial includes a monotherapy arm and a combination arm with Merck's KEYTRUDA®. Kineta aims to complete enrollment by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:02 pm

LVO

LiveOne has announced a multi-year B2B partnership with TextNow, offering exclusive content and a year of LiveOne Plus to TextNow users. This partnership is expected to drive revenue and EBITDA growth for LiveOne.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:02 pm

AAPL

QCOM

Apple's development of an in-house modem chip is progressing slowly, with a gradual implementation expected by 2025. Qualcomm, the current chip provider, is not expected to be significantly affected in the near term.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:59 pm

SONN

Sonnet BioTherapeutics shares rise following a clinical collaboration agreement with the Sarcoma Oncology Center to start a Phase 1/2a study of SON-1210 with chemotherapy for pancreatic cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:51 pm

AAPL

WLDS

Wearable Devices' Mudra Band now supports gesture controls for all Apple devices, enhancing user experience by allowing seamless switching between devices and applications.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:46 pm

HYLN

Hyliion's shares rose following a Memorandum of Understanding with Jardine Engineering Corporation to explore the KARNO generator's potential in Asian power generation markets.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:46 pm

SONN

Sonnet BioTherapeutics has entered a clinical collaboration with the Sarcoma Oncology Center to conduct a Phase 1/2a study of SON-1210, a bifunctional IL-12/IL-15 fusion protein, in combination with chemotherapy for pancreatic cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:46 pm

LIXT

LIXTE Biotechnology Holdings, Inc. (NASDAQ:LIXT) announced recent developments including a collaboration with NKI and funding support from a major pharmaceutical company for a new colorectal cancer clinical trial. The company also published preclinical data showing LB-100's potential to enhance immunotherapy benefits and appointed Jan Schellens as Chief Medical Officer.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:42 pm

AMAT

AMZN

HD

Home Depot, Amazon, and Applied Materials were discussed on CNBC's 'Final Trades'. Home Depot reported mixed Q2 results with better-than-expected margins but missed sales estimates. Amazon is forming partnerships with TikTok and Pinterest for direct shopping. Applied Materials reported strong Q3 results, beating revenue and earnings estimates.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 12:40 pm

XPON

Expion360 has partnered with Alaskan Campers to provide advanced lithium battery solutions for truck campers. This collaboration aims to enhance the energy efficiency and reliability of Alaskan Campers' products.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:39 pm